IBUPROFEN + PSEUDOEPHEDRINE CAPLETS TABLET
国家: 加拿大
语言: 英文
来源: Health Canada
产品特点
(SPC)
25-08-2016
该产品的某些文档当前不可用，您可以向我们的客户服务发送请求，我们将在获得它们后尽快通知您。
发送请求。
发送请求。
有效成分:
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
可用日期:
MARCAN PHARMACEUTICALS INC
ATC代码:
M01AE51
INN（国际名称）:
IBUPROFEN, COMBINATIONS
剂量:
200MG; 30MG
药物剂型:
TABLET
组成:
IBUPROFEN 200MG; PSEUDOEPHEDRINE HYDROCHLORIDE 30MG
给药途径:
ORAL
每包单位数:
10/24/100
处方类型:
OTC
治疗领域:
OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS
產品總結:
Active ingredient group (AIG) number: 0222394001; AHFS:
授权状态:
APPROVED
授权日期:
2016-08-23
产品特点
Page 1 of 47
PRODUCT MONOGRAPH
IBUPROFEN + PSEUDOEPHEDRINE CAPLETS
Ibuprofen and Pseudoephedrine Hydrochloride Tablets USP
Ibuprofen 200 mg, Pseudoephedrine Hydrochloride 30 mg
Caplets
Analgesic/Antipyretic/Nasal Decongestant
Marcan Pharmaceuticals Inc.
Date of Preparation:
77 Auriga Drive, Unit #4
August 23, 2016
Ottawa, Ontario
K2E 7Z7
Control# 197421
Page 2 of 47
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.................................................................... 3
SUMMARY PRODUCT INFORMATION
...........................................................................................
3
INDICATIONS AND CLINICAL USE
.................................................................................................
3
CONTRAINDICATIONS
......................................................................................................................
3
WARNINGS AND PRECAUTIONS
....................................................................................................
5
ADVERSE REACTIONS
....................................................................................................................
10
DRUG INTERACTIONS
.....................................................................................................................
17
DOSAGE AND ADMINISTRATION
.................................................................................................
20
OVERDOSAGE
...................................................................................................................................
20
ACTION AND CLINICAL PHARMACOLOGY
...............................................................................
22
STORAGE AND STABILITY
............................................................................................................
26
SPECIAL HANDLING INSTRUCTION
............................................................................................
26
DOSAGE FORMS, COMPOSITION AND PACKAGING
...............................................................
阅读完整的文件
